Consolidated Cash Flow Statement
(unaudited)
|
Six months ended June 30 |
|
|---|---|---|
(thousands of €) |
2025 |
2024 |
Net profit/loss (–) of the year |
(259,151) |
99,205 |
|
|
|
Adjustment for non-cash transactions |
168,205 |
(14,184) |
Adjustment for items to disclose separately under operating cash flow |
(22,743) |
(49,814) |
Adjustment for items to disclose under investing and financing cash flows |
(41,328) |
(62,075) |
Change in working capital other than deferred income |
112,335 |
(64,496) |
Cash used for other liabilities related to the disposal of subsidiaries |
– |
(3,598) |
Cash used for other liabilities related to the acquisition of subsidiaries |
(1,792) |
– |
Decrease in deferred income |
(117,286) |
(140,038) |
Cash used in operations |
(161,760) |
(235,000) |
|
|
|
Interest paid |
(304) |
(501) |
Interest received |
14,880 |
47,228 |
Corporate taxes paid |
(204) |
(594) |
Net cash flow used in operating activities |
(147,388) |
(188,867) |
Purchase of property, plant and equipment |
(9,250) |
(7,062) |
Purchase of intangible fixed assets |
(155) |
(65,036) |
Purchase of financial investments |
(2,087,499) |
(1,516,737) |
Investment income received related to financial investments |
42,338 |
9,558 |
Sale of financial investments |
2,201,540 |
1,717,044 |
Proceeds from settlement of hedging instrument |
22,745 |
– |
Cash in/cash out (–) from the disposal of subsidiaries, net of cash disposed of |
9,733 |
(5,209) |
Convertible loan issued to third party |
(20,000) |
– |
Acquisition of equity investments held at fair value |
– |
(36,880) |
Net cash flow generated from investing activities |
159,452 |
95,678 |
|
|
|
Payment of lease liabilities |
(1,611) |
(2,232) |
Net cash flow used in financing activities |
(1,611) |
(2,232) |
|
|
|
Increase/decrease (–) in cash and cash equivalents |
10,453 |
(95,421) |
|
|
|
Cash and cash equivalents at beginning of the period |
64,239 |
166,810 |
|
|
|
Increase/decrease (–) in cash and cash equivalents |
10,453 |
(95,421) |
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
(3,023) |
939 |
|
|
|
Cash and cash equivalents at end of the period |
71,669 |
72,328 |
The accompanying notes form an integral part of these condensed consolidated financial statements.